NIH Holds State-of-the-Science Conference
on Tobacco Use Prevention, Cessation, and Control, June 12-14,
||An impartial, independent panel will be charged
with reviewing the available scientific evidence on prevention,
cessation, and control of tobacco use. The panel will issue
a statement of its findings on the final day of the conference,
and will hold a press conference at 2:00 p.m. on Wednesday,
June 14. Convened by the Office of Medical Applications of
Research (OMAR) and the National Cancer Institute (NCI) of
the NIH, this conference is free and open to the public and
the media. Conference speakersí presentations, open discussions,
and the panelís statement will focus on these questions:
- What are the effective population- and community-based
interventions to prevent tobacco use in adolescents and
young adults, including among diverse populations?
- What are the effective strategies for increasing consumer
demand for and use of proven individually oriented cessation
treatments, including among diverse populations?
- What are the effective strategies for increasing the
implementation of proven population-level tobacco-use
cessation strategies, particularly by healthcare systems
- What is the effect of smokeless-tobacco-product marketing
and use on population harm from tobacco use?
- What is the effectiveness of prevention and of cessation
intervention in populations with co-occurring morbidities
and risk behaviors?
- What research is needed to make the most progress and
greatest public health gains nationally and internationally?
||Monday, June 12, 2006, 8:30 a.m. — 6:05
Tuesday, June 13, 2006, 8:30 a.m. — 11:15 a.m.
Wednesday, June 14, 9:00 — 11:00 a.m.
Press Conference: Wednesday, June 14, 2006, 2:00 p.m.
||Natcher Conference Center
NIH Main Campus — Building 45
9000 Rockville Pike
Bethesda, Maryland 20892
Campus visitor information: http://www.nih.gov/about/visitor/index.htm
The conference will also be webcast live at http://videocast.nih.gov/.
Tobacco use remains the nationís leading
preventable cause of premature death. Each year, more than
440,000 Americans die from disease caused by tobacco use,
accounting for one in every five deaths. Cigarette smoking
alone is responsible for more than 30% of cancer deaths
annually in the United States, and smoking is also an important
cause of death from heart disease, stroke, and chronic
obstructive pulmonary disease. Currently, there are an
estimated 44.5 million (21%) adult smokers and an estimated
3.75 million (22%) high school student smokers in the United
States. Cigarettes are the predominant form of tobacco
consumed; however, other forms of tobacco, such as smokeless
tobacco, cigars, and pipes, are also used. In addition
to the toll on human lives, tobacco use places an enormous
economic burden on society. For 1995 to 1999, estimated
annual smoking-attributable economic costs in the United
States were $75.5 billion for direct medical care for adults
and $81.9 billion for lost productivity.
Despite enormous progress in reducing the prevalence of
tobacco use in this country, it is unlikely that the Healthy
People 2010 objectives of reducing smoking prevalence to
12% or less in adults and 16% or less in youth will be
reached on schedule. A better understanding of how effective
strategies for prevention and treatment can be developed
and implemented across diverse segments of the population
is crucial to accelerate progress; meeting the Healthy
People 2010 prevalence goals would prevent a projected
additional 7.1 million premature deaths after 2010. This
conference has been planned to facilitate an objective
review of the available evidence to clarify what is known
and what research gaps remain concerning the conference
The conference is sponsored by OMAR and the National Cancer Institute, through the NIH Consensus Development Program. A background document about the conference process is available at http://consensus.nih.gov/forthemedia.htm.
For More Information:
Conference agenda, speakers, logistics, and online registration are available at http://consensus.nih.gov. To schedule interviews, please contact Kelli Marciel by e-mail at email@example.com or by phone at (301) 496-4819.
Note to Reporters:
Reporters viewing the press conference via webcast at http://videocast.nih.gov will be able to submit questions on-line through the videocast Web site beginning at 1:30 p.m. on Wednesday, June 14.
Note to TV Editors:
The press conference on Wednesday, June 14 will be broadcast live via satellite at the following coordinates:
C-Band Galaxy 3C
Orbital Location: 95 degrees west
Downlink Frequency: 4160 H
Audio: 6.2/ 6.8
Test time: 1:30-2:00 p.m. ET
Broadcast: 2:00-3:00 p.m. ET
Note to Radio Editors:
An audio report of the conference results will be available after 4:00 p.m. Wednesday, June 14, from the NIH Radio News Service by calling 1-800-MED-DIAL (1-800-633-3425) or visiting http://www.nih.gov/news/radio/index.htm.
The Office of the Director, the central office at NIH, is responsible
for setting policy for NIH, which includes 27 Institutes and Centers.
This involves planning, managing, and coordinating the programs and
activities of all NIH components. The Office of the Director also includes
program offices which are responsible for stimulating specific areas
of research throughout NIH. Additional information is available at http://www.nih.gov/icd/od/.
The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and
is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic,
clinical and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit www.nih.gov.